| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 15.767 | 36.282 | 22.173 | 47.392 | 36.748 | 19.894 | 3.517 |
| Total Income - EUR | - | - | - | 15.956 | 36.287 | 22.173 | 47.392 | 36.748 | 19.906 | 3.517 |
| Total Expenses - EUR | - | - | - | 12.837 | 19.115 | 24.637 | 29.994 | 37.636 | 38.122 | 21.460 |
| Gross Profit/Loss - EUR | - | - | - | 3.119 | 17.172 | -2.464 | 17.398 | -888 | -18.215 | -17.942 |
| Net Profit/Loss - EUR | - | - | - | 2.964 | 16.085 | -2.949 | 15.998 | -1.825 | -18.413 | -17.977 |
| Employees | - | - | - | 1 | 0 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Nanosof Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 30 | 71 | 78 | 368 | 352 | 188 | 146 |
| Current Assets | - | - | - | 6.469 | 24.309 | 20.642 | 36.540 | 48.706 | 24.574 | 16.146 |
| Inventories | - | - | - | -533 | 11.207 | 0 | 3.364 | 8.833 | 7.102 | 4.498 |
| Receivables | - | - | - | 1.952 | 7.173 | 7.651 | 9.470 | 10.748 | 11.854 | 10.755 |
| Cash | - | - | - | 5.050 | 5.929 | 12.991 | 23.707 | 29.125 | 5.617 | 893 |
| Shareholders Funds | - | - | - | 3.007 | 19.034 | 15.725 | 31.374 | 29.646 | 1.741 | -16.246 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.491 | 5.346 | 5.039 | 5.659 | 19.583 | 23.214 | 32.921 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Nanosof Health S.r.l.